Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Scientific Reports
|
February 13, 2025
Predicting low density lipoprotein cholesterol target attainment using machine learning in patients with coronary artery disease receiving moderate-dose statin therapy
Jiye Han, Yunha Kim, Hee Jun Kang, et al.
Journal of Anesthesia
|
February 22, 2018
The effect of sevoflurane on retinal angiogenesis in a mouse model of oxygen-induced retinopathy
Hee Young Kim, Seung-Hoon Baek, Seong Wan Baik, et al.
BMC Medical Informatics and Decision Making
|
August 12, 2025
Leveraging BERT for embedding ICD codes from large scale cardiovascular EMR data to understand patient diagnostic patterns
Minkyoung Kim, Yunha Kim, Hee Jun Kang, et al.
BMC Medical Informatics and Decision Making
|
November 20, 2024
Explainable predictions of a machine learning model to forecast the postoperative length of stay for severe patients: machine learning model development and evaluation
Ha Na Cho, Imjin Ahn, Hansle Gwon, et al.
Blood Advances
|
May 13, 2020
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
Je-Hwan Lee, Stefan Faderl, John M Pagel, et al.
Metabolites
|
February 25, 2023
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations
Ahmed Elkamhawy, Na Kyoung Oh, Noha A Gouda, et al.
JMIR Medical Informatics
|
November 18, 2024
Task-Specific Transformer-Based Language Models in Health Care: Scoping Review
Ha Na Cho, Tae Joon Jun, Young-Hak Kim, et al.
Journal of Medicinal Chemistry
|
October 10, 2017
Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism
Ravi Naik, Hyun Seung Ban, Kyusic Jang, et al.
Journal of Medicinal Chemistry
|
April 22, 2020
Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy
Aneesh Sivaraman, Dae Gyu Kim, Deepak Bhattarai, et al.
Heliyon
|
February 2, 2024
Are polypharmacy side effects predicted by public data still valid in real-world data?
Gaeun Kee, Hee Jun Kang, Imjin Ahn, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Scientific Reports
|
February 13, 2025
Predicting low density lipoprotein cholesterol target attainment using machine learning in patients with coronary artery disease receiving moderate-dose statin therapy
Jiye Han, Yunha Kim, Hee Jun Kang, et al.
Journal of Anesthesia
|
February 22, 2018
The effect of sevoflurane on retinal angiogenesis in a mouse model of oxygen-induced retinopathy
Hee Young Kim, Seung-Hoon Baek, Seong Wan Baik, et al.
BMC Medical Informatics and Decision Making
|
August 12, 2025
Leveraging BERT for embedding ICD codes from large scale cardiovascular EMR data to understand patient diagnostic patterns
Minkyoung Kim, Yunha Kim, Hee Jun Kang, et al.
BMC Medical Informatics and Decision Making
|
November 20, 2024
Explainable predictions of a machine learning model to forecast the postoperative length of stay for severe patients: machine learning model development and evaluation
Ha Na Cho, Imjin Ahn, Hansle Gwon, et al.
Blood Advances
|
May 13, 2020
Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
Je-Hwan Lee, Stefan Faderl, John M Pagel, et al.
Metabolites
|
February 25, 2023
Novel Hybrid Indole-Based Caffeic Acid Amide Derivatives as Potent Free Radical Scavenging Agents: Rational Design, Synthesis, Spectroscopic Characterization, In Silico and In Vitro Investigations
Ahmed Elkamhawy, Na Kyoung Oh, Noha A Gouda, et al.
JMIR Medical Informatics
|
November 18, 2024
Task-Specific Transformer-Based Language Models in Health Care: Scoping Review
Ha Na Cho, Tae Joon Jun, Young-Hak Kim, et al.
Journal of Medicinal Chemistry
|
October 10, 2017
Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism
Ravi Naik, Hyun Seung Ban, Kyusic Jang, et al.
Journal of Medicinal Chemistry
|
April 22, 2020
Synthesis and Structure-Activity Relationships of Arylsulfonamides as AIMP2-DX2 Inhibitors for the Development of a Novel Anticancer Therapy
Aneesh Sivaraman, Dae Gyu Kim, Deepak Bhattarai, et al.
Heliyon
|
February 2, 2024
Are polypharmacy side effects predicted by public data still valid in real-world data?
Gaeun Kee, Hee Jun Kang, Imjin Ahn, et al.
Page
of 11